Device Regulation Under Gottlieb & Trump - Webinar Recording/Transcript
Device Regulation under Gottlieb & Trump
In Part II of FDAnews’s Expert Insight Series, our panel dives deep into device regulation, policy and enforcement.
New device policies will have been established. New Trump-Gottlieb appointees will be taking their seats. Many new devices will have been approved. And it will be coming clear how fundamental standards for approval will differ from the past.
Perhaps most important, policies on product approvals and other key issues will be starting to emerge: Relationships between medical devices and combination products, fast-track approvals, clinical trials, and more.
Given the fluid nature of events though, panelists are certain to range beyond the topic of the day. Other installments include:
- What We’ve Learned Since Scott Gottlieb Was Confirmed
- Pharmaceutical Regulation under Gottlieb-Trump
- The FDA Under Gottlieb-Trump and a Look Ahead
If you are a devicemaker, you know this is the must-attend session. But it makes sense to register for them all. Scott Gottlieb’s FDA is now your FDA.